Labcorp (LH) Competitors $276.51 -1.59 (-0.57%) Closing price 08/21/2025 03:59 PM EasternExtended Trading$278.03 +1.52 (+0.55%) As of 08:45 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock LH vs. HOLX, HSIC, MEDP, AMN, CAH, CHE, DGX, MCK, TMO, and WSTShould you be buying Labcorp stock or one of its competitors? The main competitors of Labcorp include Hologic (HOLX), Henry Schein (HSIC), Medpace (MEDP), AMN Healthcare Services (AMN), Cardinal Health (CAH), Chemed (CHE), Quest Diagnostics (DGX), McKesson (MCK), Thermo Fisher Scientific (TMO), and West Pharmaceutical Services (WST). These companies are all part of the "medical" sector. Labcorp vs. Its Competitors Hologic Henry Schein Medpace AMN Healthcare Services Cardinal Health Chemed Quest Diagnostics McKesson Thermo Fisher Scientific West Pharmaceutical Services Labcorp (NYSE:LH) and Hologic (NASDAQ:HOLX) are both large-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, earnings, profitability, dividends, risk, institutional ownership, media sentiment and analyst recommendations. Do analysts rate LH or HOLX? Labcorp presently has a consensus price target of $289.58, indicating a potential upside of 4.73%. Hologic has a consensus price target of $78.00, indicating a potential upside of 16.12%. Given Hologic's higher probable upside, analysts clearly believe Hologic is more favorable than Labcorp.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Labcorp 1 Sell rating(s) 3 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.62Hologic 0 Sell rating(s) 8 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 2.59 Do institutionals and insiders have more ownership in LH or HOLX? 95.9% of Labcorp shares are owned by institutional investors. Comparatively, 94.7% of Hologic shares are owned by institutional investors. 0.8% of Labcorp shares are owned by company insiders. Comparatively, 1.9% of Hologic shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Does the media favor LH or HOLX? In the previous week, Labcorp had 6 more articles in the media than Hologic. MarketBeat recorded 29 mentions for Labcorp and 23 mentions for Hologic. Hologic's average media sentiment score of 1.47 beat Labcorp's score of 1.32 indicating that Hologic is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Labcorp 24 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Hologic 12 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has stronger earnings and valuation, LH or HOLX? Hologic has lower revenue, but higher earnings than Labcorp. Hologic is trading at a lower price-to-earnings ratio than Labcorp, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLabcorp$13.48B1.70$746M$9.0630.52Hologic$4.04B3.70$789.50M$2.4127.87 Which has more volatility and risk, LH or HOLX? Labcorp has a beta of 0.78, indicating that its share price is 22% less volatile than the S&P 500. Comparatively, Hologic has a beta of 0.49, indicating that its share price is 51% less volatile than the S&P 500. Is LH or HOLX more profitable? Hologic has a net margin of 13.79% compared to Labcorp's net margin of 5.66%. Hologic's return on equity of 19.69% beat Labcorp's return on equity.Company Net Margins Return on Equity Return on Assets Labcorp5.66% 15.45% 7.02% Hologic 13.79%19.69%10.82% SummaryHologic beats Labcorp on 9 of the 17 factors compared between the two stocks. Get Labcorp News Delivered to You Automatically Sign up to receive the latest news and ratings for LH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LH vs. The Competition Export to ExcelMetricLabcorpMedical Services IndustryMedical SectorNYSE ExchangeMarket Cap$23.11B$7.75B$5.79B$20.96BDividend Yield1.04%2.64%3.84%3.59%P/E Ratio30.5276.3830.3528.27Price / Sales1.7030.85449.7053.25Price / Cash12.4124.8637.1523.84Price / Book2.7116.819.035.24Net Income$746M$243.33M$3.26B$992.10M7 Day Performance2.18%-1.29%0.39%0.01%1 Month Performance9.58%-1.47%3.22%-0.07%1 Year Performance20.01%11.71%29.59%10.34% Labcorp Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LHLabcorp4.6326 of 5 stars$276.51-0.6%$289.58+4.7%+20.9%$23.11B$13.48B30.5270,000Positive NewsHOLXHologic4.8256 of 5 stars$67.99-0.1%$77.83+14.5%-16.1%$15.12B$4.03B28.217,063Positive NewsAnalyst RevisionHSICHenry Schein4.2031 of 5 stars$66.10+0.2%$75.58+14.3%-2.4%$8.02B$12.67B21.3225,000Positive NewsMEDPMedpace4.3029 of 5 stars$449.77+3.6%$406.60-9.6%+14.6%$12.63B$2.11B33.445,900Positive NewsInsider TradeAMNAMN Healthcare Services4.4509 of 5 stars$16.46-4.6%$30.25+83.8%-61.5%$629.98M$2.85B-2.122,968CAHCardinal Health4.8719 of 5 stars$158.07+0.4%$158.07+0.0%+38.4%$37.73B$222.29B24.6648,900Trending NewsDividend AnnouncementInsider TradeCHEChemed4.9928 of 5 stars$432.47-0.7%$579.75+34.1%-21.1%$6.30B$2.51B22.2315,695Positive NewsDGXQuest Diagnostics4.4896 of 5 stars$178.29+0.7%$186.00+4.3%+20.0%$19.94B$9.87B21.3556,000News CoveragePositive NewsInsider TradeMCKMcKesson4.2445 of 5 stars$673.74+0.8%$718.73+6.7%+26.5%$83.80B$359.05B26.8645,000Positive NewsInsider TradeTMOThermo Fisher Scientific4.9564 of 5 stars$462.59+0.4%$593.00+28.2%-20.8%$174.68B$43.21B26.75125,000Trending NewsInsider TradeAnalyst RevisionWSTWest Pharmaceutical Services4.6867 of 5 stars$240.40-0.2%$320.71+33.4%-20.4%$17.29B$2.96B35.9910,600Positive News Related Companies and Tools Related Companies HOLX Alternatives HSIC Alternatives MEDP Alternatives AMN Alternatives CAH Alternatives CHE Alternatives DGX Alternatives MCK Alternatives TMO Alternatives WST Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:LH) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersSilver’s Still Under $35… For Now.Silver is trading around $33—but insiders are betting on a $70 breakout by year’s end. With supply shrinkin...GoldenCrest Metals | SponsoredOne tiny company just cracked Google’s $19B problemGoogle’s AI-powered search could cost $20 billion a year in electricity—nearly half its profits. But new resea...True Market Insiders | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredUS attacks China, September 30?The White House just ordered more than 400 government agencies to prepare for the next phase of America’s econ...Stansberry Research | SponsoredI trusted Trump and got screwedPorter Stansberry says he got one thing wrong—and now millions of Americans could pay the price. After warning...Porter & Company | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Labcorp Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Labcorp With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access